Quest Diagnostics (DGX) Accumulated Expenses (2010 - 2025)

Quest Diagnostics (DGX) has 14 years of Accumulated Expenses data on file, last reported at $338.0 million in Q4 2025.

• Quarterly Accumulated Expenses rose 10.46% year-over-year to $338.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $338.0 million (up 10.46% YoY) and the FY2025 annual result came in at $338.0 million, up 10.46% from the prior year.
• Accumulated Expenses rose to $338.0 million in Q4 2025 per DGX's latest filing, from $306.0 million in the prior quarter.
• The five-year high for Accumulated Expenses was $460.0 million in Q4 2021, with the low at $287.0 million in Q4 2023.
• Average Accumulated Expenses over 5 years is $356.6 million, with a median of $338.0 million recorded in 2025.
• Year-over-year, Accumulated Expenses climbed 29.21% in 2021 and retreated 26.79% in 2023.
• Quest Diagnostics' Accumulated Expenses stood at $460.0 million in 2021, then slipped by 14.78% to $392.0 million in 2022, then fell by 26.79% to $287.0 million in 2023, then gained by 6.62% to $306.0 million in 2024, then gained by 10.46% to $338.0 million in 2025.
• Business Quant data shows DGX's Accumulated Expenses at $338.0 million in Q4 2025, $306.0 million in Q4 2024, and $287.0 million in Q4 2023.